HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Suppression of apoptosis in C3H mouse liver tumors by activated Ha-ras oncogene.

Abstract
Liver tumors were induced in male C3H mice by a single injection of N-nitrosodiethylamine and characterized with respect to the presence of base substitutions in the hot-spot position at codon 61 of the Ha-ras proto-oncogene. An increase in Ha-ras mutation prevalence was found with time after induction of tumors, suggesting that the activated ras gene provides a selective growth advantage. However, no significant differences in 5-bromodeoxyuridine labeling indices were evident between ras mutated and ras wild-type tumors, demonstrating that cell division rates in the two tumor populations were very similar. Apoptotic indices were determined by counting eosinophilic apoptotic bodies. The frequency of occurrence of apoptotic bodies was found to be approximately five times lower in tumors with Ha-ras mutations when compared with tumors not showing the mutation. This demonstrates that the activated p21(Ras) protein has anti-apoptotic activity in transformed mouse hepatocytes in vivo and suggests that the preferential outgrowth of Ha-ras-mutated hepatoma cells is mediated by suppression of apoptosis rather than by stimulation of cell division.
AuthorsS Frey, A Buchmann, W Bursch, R Schulte-Hermann, M Schwarz
JournalCarcinogenesis (Carcinogenesis) Vol. 21 Issue 2 Pg. 161-6 (Feb 2000) ISSN: 0143-3334 [Print] England
PMID10657952 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Codon
  • Diethylnitrosamine
Topics
  • Animals
  • Apoptosis (genetics)
  • Cell Division
  • Codon (genetics)
  • Diethylnitrosamine
  • Gene Expression Regulation, Neoplastic
  • Genes, ras
  • Liver Neoplasms, Experimental (chemically induced, genetics, pathology)
  • Male
  • Mice
  • Mice, Inbred C3H

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: